BioSpace News Archive

According to Vision Research Reports, the global microcarrier market size is expected to hit around USD 5.10 billion by 2030 and growing at a CAGR of 11.4% from 2022 to 2030.

According to Vision Research Reports, the global multiplex assay market was surpassed at USD 2.06 billion in 2021 and is expected to hit around USD 3.97 billion by 2030, growing at a CAGR of 7.56% from 2022 to 2030.

Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the third quarter 2022 on Thursday, November 3, 2022, after the close of U.S.-based financial markets.

Biohaven Ltd. (NYSE: BHVN) (the “Company” or “Biohaven”) today announced the closing of an underwritten public offering of 28,750,000 of its common shares, which includes the full exercise of the underwriters’ option to purchase 3,750,000 additional shares, at the public offering price of $10.50 per share.

PacBio, a leading developer of high-quality, highly accurate sequencing solutions, announced the commencement of external beta testing of the Onso™ sequencing system.

PacBio, a leading developer of high-quality, highly accurate sequencing solutions, announced the Revio™ long-read sequencing system, which will enable customers to dramatically scale their use of PacBio’s celebrated HiFi sequencing technology.

Bristol Myers Squibb (NYSE:BMY) today reports results for the third quarter of 2022, which reflect strong in-line and new product portfolio growth.

Mevion Medical Systems is pleased to announce it has entered into a contract with the Froedtert & the Medical College of Wisconsin health network to bring the MEVION S250i Proton Therapy System® to Wisconsin.

CareDx, Inc. today announced its leading presence as a Diamond Level sponsor at the 48th annual meeting of the American Society for Histocompatibility and Immunogenetics (ASHI) being held in Las Vegas, Nevada from October 24 to October 28.

Precision Genomics is pleased to announce that our new mRNA technology may offer a solution to assist in the diagnosis of and establish treatment protocols for, the current healthcare crisis, Long Covid.